{"DataElement":{"publicId":"3104081","version":"2","preferredName":"Follow-up Metastasis Assessment Outcome Success Margin Status","preferredDefinition":"Text term to describe the status of tissue margin following surgical resection for a metastatic progression procedure.","longName":"3104079v1.0:2608700v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3104079","version":"1","preferredName":"Follow-up Metastasis Assessment Outcome Success","preferredDefinition":"_The final result of a determination of the value, significance, or extent of.__Cancer that has spread from the organ in which it first appeared to another organ. For example, breast cancer cells may spread (metastasize) to the lungs and cause the growth of a new tumor. When this happens, the disease is called metastatic breast cancer._The process by which information about the health status of an individual is obtained after a study has officially closed._The result of an action._An event that accomplishes its intended purpose.","longName":"3104077v1.0:2786715v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3104077","version":"1","preferredName":"Follow-up Metastasis Assessment","preferredDefinition":"The process by which information about the health status of an individual is obtained after a study has officially closed.:Cancer that has spread from the organ in which it first appeared to another organ. For example, breast cancer cells may spread (metastasize) to the lungs and cause the growth of a new tumor. When this happens, the disease is called metastatic breast cancer.:The final result of a determination of the value, significance, or extent of.","longName":"C16033:C19151:C25367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Follow-Up","conceptCode":"C16033","definition":"The process by which information about the health status of an individual is obtained after a study has officially closed; an activity that continues something that has already begun or that repeats something that has already been done.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Metastasis","conceptCode":"C19151","definition":"The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25367","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87E3E3C1-F234-A523-E040-BB89AD437986","latestVersionIndicator":"Yes","beginDate":"2010-05-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-31","modifiedBy":"ONEDATA","dateModified":"2010-05-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2786715","version":"1","preferredName":"Outcome Success","preferredDefinition":"Outcome; a phenomenon that follows and is caused by some previous phenomenon.:Success; an event that accomplishes its intended purpose.","longName":"C20200:C25362","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Success","conceptCode":"C25362","definition":"An event that accomplishes its intended purpose.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5758397B-E829-370D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-09-20","modifiedBy":"ONEDATA","dateModified":"2008-09-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87E3E3C1-F242-A523-E040-BB89AD437986","latestVersionIndicator":"Yes","beginDate":"2010-05-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-31","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2608700","version":"1.1","preferredName":"Margin Status","preferredDefinition":"Text terms to describe the status of a tissue margin.","longName":"MARG_STAT","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No source documentation","valueDescription":"No/Not in source document","ValueMeaning":{"publicId":"2604857","version":"1","preferredName":"No/Not in source document","longName":"2604857","preferredDefinition":"Data from an original source is not present, accessible or ready for use or service.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Source Data Not Available","conceptCode":"C67329","definition":"Data from an original source is not present, accessible or ready for use or service.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AB6C02E-D628-0591-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-03-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-03-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/19/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4408282D-3DA7-705E-E053-F662850A7943","beginDate":"2007-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-19","modifiedBy":"ONEDATA","dateModified":"2016-12-19","deletedIndicator":"No"},{"value":"R0","valueDescription":"All Margins Pathologically Negative","ValueMeaning":{"publicId":"2558208","version":"1","preferredName":"All Margins Pathologically Negative","longName":"2558208","preferredDefinition":"Indicates the absence of tumor cells at the edge of a surgically excised specimen.: Cancer cells that remain after attempts to remove the cancer have been made.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negative Surgical Margin","conceptCode":"C48621","definition":"Indicates the absence of tumor cells at the edge of a surgically excised specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Residual Disease","conceptCode":"C4809","definition":"Tumor cells that remain in the body following cancer treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B06D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/19/2015. Changed all uppercase Long Name to capitalize each word. mc 12/19/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4408282D-3DB1-705E-E053-F662850A7943","beginDate":"2004-04-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-19","modifiedBy":"ONEDATA","dateModified":"2016-12-19","deletedIndicator":"No"},{"value":"R1","valueDescription":"Microscopically Positive Margins or Microscopic Residual Disease","ValueMeaning":{"publicId":"2559219","version":"1","preferredName":"Microscopically Positive Margins or Microscopic Residual Disease","longName":"2559219","preferredDefinition":"Indicates the presence of tumor cells at the edge of a surgically excised specimen.: A finding resulting from the examination of a tissue sample under light or electron microscopy.: Cancer cells that remain after attempts to remove the cancer have been made.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive Surgical Margin","conceptCode":"C48620","definition":"Indicates the presence of tumor cells at the edge of a surgically excised specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Histopathology Result","conceptCode":"C83490","definition":"A finding resulting from the examination of a tissue sample under light or electron microscopy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Residual Disease","conceptCode":"C4809","definition":"Tumor cells that remain in the body following cancer treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B460-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/19/2015. Changed all uppercase Long Name to capitalize each word. mc 12/19/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4408282D-3DBB-705E-E053-F662850A7943","beginDate":"2004-04-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-19","modifiedBy":"ONEDATA","dateModified":"2016-12-19","deletedIndicator":"No"},{"value":"R2","valueDescription":"Macroscopically Positive Margins or Gross Residual Disease","ValueMeaning":{"publicId":"2559141","version":"1","preferredName":"Macroscopically Positive Margins or Gross Residual Disease","longName":"2559141","preferredDefinition":"The presence of macroscopically visible residual tumor at the edge of a surgically excised specimen.: Visible to the naked eye.: Cancer cells that remain after attempts to remove the cancer have been made.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Macroscopically Positive Surgical Margin","conceptCode":"C120274","definition":"The presence of macroscopically visible residual tumor at the edge of a surgically excised specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Gross","conceptCode":"C43566","definition":"Visible to the naked eye.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Residual Disease","conceptCode":"C4809","definition":"Tumor cells that remain in the body following cancer treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B412-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/19/2015. Changed all uppercase Long Name to capitalize each word. mc 12/19/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4408282D-3DC5-705E-E053-F662850A7943","beginDate":"2004-04-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-19","modifiedBy":"ONEDATA","dateModified":"2016-12-19","deletedIndicator":"No"},{"value":"RX","valueDescription":"Presence of Residual Disease Cannot Be Assessed","ValueMeaning":{"publicId":"2559858","version":"1","preferredName":"Presence of Residual Disease Cannot Be Assessed","longName":"2559858","preferredDefinition":"Cancer cells that remain after attempts to remove the cancer have been made.: Being or existing in a specified place or at the specified time.: Aspects of the context prevent the evaluation needed to determine a value.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Residual Disease","conceptCode":"C4809","definition":"Tumor cells that remain in the body following cancer treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cannot Be Assessed","conceptCode":"C48657","definition":"Aspects of the context prevent the evaluation needed to determine a value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B6DF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/19/2015. Changed all uppercase Long Name to capitalize each word. mc 12/19/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4408282D-3DCF-705E-E053-F662850A7943","beginDate":"2002-02-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-19","modifiedBy":"ONEDATA","dateModified":"2016-12-19","deletedIndicator":"No"},{"value":"Not evaluated","valueDescription":"Not Evaluated","ValueMeaning":{"publicId":"5607983","version":"1","preferredName":"Not Evaluated","longName":"5607983","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Evaluation","conceptCode":"C25214","definition":"Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4408282D-3DE1-705E-E053-F662850A7943","latestVersionIndicator":"Yes","beginDate":"2016-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4408282D-3DFA-705E-E053-F662850A7943","beginDate":"2016-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-19","modifiedBy":"ONEDATA","dateModified":"2016-12-19","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008563","version":"1","preferredName":"Therapy Results","preferredDefinition":"the results or effects (does not include CTC Adverse Events) of therapeutic agents or procedures administered to the patient.","longName":"TX_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6690D31-4081-494A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-06","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-02-11","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2608699","version":"1","preferredName":"Margin Status","preferredDefinition":"Margin; the boundary line or the area immediately inside the boundary.:A condition or state at a particular time.","longName":"C25563:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Margin","conceptCode":"C25563","definition":"A boundary line or the area immediately inside the boundary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2B1E2B8A-8DB4-37B4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-03-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-03-07","modifiedBy":"ONEDATA","dateModified":"2007-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4408282D-3D90-705E-E053-F662850A7943","latestVersionIndicator":"Yes","beginDate":"2007-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","changeDescription":"Versioned to extend max length and add PV as requested by K.Wildermuth. mc 12/19/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]},{"publicId":"5589063","version":"1","longName":"CDDP/CTSP (Cancer Driver Discovery Program/Clinical Trial Sequencing Project)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"5589068","version":"1","longName":"CDDP/CTSP","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Residual tumor after Surgery","type":"Preferred Question Text","description":"Residual tumor after Surgery for New Tumor Event Metastatic","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4409C7DB-6F0D-7F83-E053-F662850A7BEF","latestVersionIndicator":"Yes","beginDate":"2016-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-19","modifiedBy":"TSESU","dateModified":"2018-07-17","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of G. Diaz 5/2010 Versioned to extend max length and add PV as requested by K.Wildermuth. mc 12/19/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}